These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 27132208)
1. Evaluating the management of 493 patients presenting with bacteremia in 23 northern French hospitals. Alfandari S; Cabaret P; Nguyen S; Descamps D; Vachée A; Cattoen C; Van Grunderbeeck N; Med Mal Infect; 2016 Jun; 46(4):194-9. PubMed ID: 27132208 [TBL] [Abstract][Full Text] [Related]
2. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network]. Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology and susceptibility to antimicrobials in community, hospital and long-term care facility bacteremia in northern Israel: a 6 year surveillance. Chazan B; Raz R; Teitler N; Nitzan O; Edelstein H; Colodner R Isr Med Assoc J; 2009 Oct; 11(10):592-7. PubMed ID: 20077944 [TBL] [Abstract][Full Text] [Related]
4. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center. Kao CH; Kuo YC; Chen CC; Chang YT; Chen YS; Wann SR; Liu YC J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617 [TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. Anderson DJ; Moehring RW; Sloane R; Schmader KE; Weber DJ; Fowler VG; Smathers E; Sexton DJ PLoS One; 2014; 9(3):e91713. PubMed ID: 24643200 [TBL] [Abstract][Full Text] [Related]
6. [Economic burden of methicillin-resistant Staphylococcus aureus bacteremia in critical care patients in hospitals in Bogotá]. Barrero LI; Castillo JS; Leal AL; Sánchez R; Cortés JA; Alvarez CA; González AL Biomedica; 2014; 34(3):345-53. PubMed ID: 25504122 [TBL] [Abstract][Full Text] [Related]
7. ETIOLOGY AND RESISTANCE PROFILE OF ISOLATED STRAINS FROM SEVERE SYSTEMIC INFECTIONS IN PATIENTS WITH IMMUNODEPRESSION--EXPERIENCE OF THE IASI INFECTIOUS DISEASES HOSPITAL 2011-2014. Pleşca CE; Luca MC; Luca AS; Constantinescu S; Iancu LS Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1141-6. PubMed ID: 26793861 [TBL] [Abstract][Full Text] [Related]
8. Resistance profiles and risk factors of resistant microorganisms in bacteraemia of abdominal origin. Martín Jaramago J; Armero Ibáñez R; Camarena Miñana JJ; Morales Suárez-Varela M Rev Esp Anestesiol Reanim; 2017 Nov; 64(9):490-498. PubMed ID: 28434558 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study. Khan FY; Elshafie SS; Almaslamani M; Abu-Khattab M; El Hiday AH; Errayes M; Almaslamani E Travel Med Infect Dis; 2010 Nov; 8(6):377-87. PubMed ID: 21074495 [TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals. Son JS; Song JH; Ko KS; Yeom JS; Ki HK; Kim SW; Chang HH; Ryu SY; Kim YS; Jung SI; Shin SY; Oh HB; Lee YS; Chung DR; Lee NY; Peck KR J Korean Med Sci; 2010 Jul; 25(7):992-8. PubMed ID: 20592888 [TBL] [Abstract][Full Text] [Related]
11. Patients with community-acquired bacteremia of unknown origin: clinical characteristics and usefulness of microbiological results for therapeutic issues: a single-center cohort study. Courjon J; Demonchy E; Degand N; Risso K; Ruimy R; Roger PM Ann Clin Microbiol Antimicrob; 2017 May; 16(1):40. PubMed ID: 28526094 [TBL] [Abstract][Full Text] [Related]
12. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy. Ramsamy Y; Muckart DJ; Han KS S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954 [TBL] [Abstract][Full Text] [Related]
13. Age-Related Trends in Adults with Community-Onset Bacteremia. Lee CC; Wang JL; Lee CH; Hung YP; Hong MY; Chang CM; Ko WC Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923864 [TBL] [Abstract][Full Text] [Related]
14. Impact of an antimicrobial stewardship initiative on time to administration of empirical antibiotic therapy in hospitalized patients with bacteremia. Bias TE; Vincent WR; Trustman N; Berkowitz LB; Venugopalan V Am J Health Syst Pharm; 2017 Apr; 74(7):511-519. PubMed ID: 28336761 [TBL] [Abstract][Full Text] [Related]
15. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012 [TBL] [Abstract][Full Text] [Related]
16. Comparative clinical characteristics and outcomes of patients with community acquired bacteremia caused by Escherichia coli, Burkholderia pseudomallei and Staphylococcus aureus: A prospective observational study (Ubon-sepsis). Somayaji R; Hantrakun V; Teparrukkul P; Wongsuvan G; Rudd KE; Day NPJ; West TE; Limmathurotsakul D PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009704. PubMed ID: 34478439 [TBL] [Abstract][Full Text] [Related]
17. Approach of empirical antibiotic treatment: analyzing bacterial resistance of community-acquired bacteremia. Young TG; Chen YS; Yen MY J Microbiol Immunol Infect; 2010 Feb; 43(1):43-6. PubMed ID: 20434122 [TBL] [Abstract][Full Text] [Related]
18. Bacteraemia in a community and a university hospital. Elhanan G; Raz R; Pitlik SD; Sharir R; Konisberger H; Samra Z; Kennes Y; Drucker M; Leibovici L J Antimicrob Chemother; 1995 Oct; 36(4):681-95. PubMed ID: 8591943 [TBL] [Abstract][Full Text] [Related]
19. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135 [TBL] [Abstract][Full Text] [Related]
20. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]